Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.25 USD | -6.09% | -22.21% | 0.00% |
Apr. 22 | Guggenheim Starts Coverage on Boundless Bio With Buy Rating, $24 Price Target | MT |
Apr. 22 | Piper Sandler Starts Audentes Therapeutics With Overweight Rating, $20 Price Target | MT |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 161M |
---|---|---|---|---|---|
Net income 2024 * | -69M | Net income 2025 * | -96M | EV / Sales 2024 * | - |
Net cash position 2024 * | 30.75M | Net cash position 2025 * | 36.28M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.95
x | P/E ratio 2025 * |
-1.72
x | Employees | 72 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 88.54% |
1 day | -6.09% | ||
1 week | -22.21% | ||
Current month | -20.50% | ||
1 month | -23.84% |
Date | Price | Change | Volume |
---|---|---|---|
24-06-13 | 7.25 | -6.09% | 57,921 |
24-06-12 | 7.72 | -16.27% | 154,625 |
24-06-11 | 9.22 | -1.81% | 15,880 |
24-06-10 | 9.39 | -2.39% | 41,957 |
24-06-07 | 9.62 | +3.22% | 41,911 |
Delayed Quote Nasdaq, June 13, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
0.00% | 161M | |
+17.73% | 124B | |
+16.88% | 111B | |
-9.04% | 23.17B | |
+5.15% | 22.94B | |
-38.15% | 17.42B | |
-7.75% | 17.42B | |
-14.69% | 16.9B | |
+3.42% | 13.71B | |
+29.63% | 11.82B |
- Stock Market
- Equities
- BOLD Stock